within Pharmacolibrary.Drugs.ATC.J;

model J01MB03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.75,
    Cl             = 8.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.03,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.011666666666666665,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01MB03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Piromidic acid is a synthetic antibacterial agent of the pyridopyrimidine class, formerly used primarily to treat urinary tract infections. It is a quinolone derivative. It is not widely approved or used in current clinical practice in most countries, and its use is now largely historical.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult healthy subjects; no published human PK studies found.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01MB03;
